Merck | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Abbott USD 14.16B 745M 2024-12
ALKERMES USD 465.2M 11.5M 2024-12
Amgen USD 23.1B 2.79B 2024-12
AstraZeneca USD 29.13B 1.26B 2025-03
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Indivior 1.01B 66M 2025-03
J&J USD 50.32B 1.44B 2024-12
Medtronic USD 11.84B 355M 2025-01
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Novartis USD 28.69B 560M 2024-12
Novo Nordisk 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Prestige Brands USD 102.54M 4.36M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
Sanofi 29.16B 865M 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Merck Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.